Therapy-related myeloproliferative neoplasm with ETV6-PDGFRB rearrangement following treatment of acute promyelocytic leukemia

Ann Hematol. 2011 Dec;90(12):1477-9. doi: 10.1007/s00277-011-1188-1. Epub 2011 Feb 25.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Antineoplastic Agents* / adverse effects
  • Antineoplastic Agents* / therapeutic use
  • Gene Rearrangement
  • Humans
  • Karyotyping
  • Leukemia, Promyelocytic, Acute* / drug therapy
  • Leukemia, Promyelocytic, Acute* / genetics
  • Male
  • Middle Aged
  • Myeloproliferative Disorders / chemically induced*
  • Myeloproliferative Disorders / genetics*
  • Oncogene Proteins, Fusion / genetics*
  • Translocation, Genetic*
  • Tretinoin* / adverse effects
  • Tretinoin* / therapeutic use

Substances

  • Antineoplastic Agents
  • ETV6-PDGFRB fusion protein, human
  • Oncogene Proteins, Fusion
  • Tretinoin